Dr Jeffrey Beechert, MD | |
1980 Crompond Rd, Cortlandt Manor, NY 10567-4144 | |
(914) 734-3600 | |
(914) 734-3600 |
Full Name | Dr Jeffrey Beechert |
---|---|
Gender | Male |
Speciality | Critical Care (intensivists) |
Experience | 36 Years |
Location | 1980 Crompond Rd, Cortlandt Manor, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407833833 | NPI | - | NPPES |
01287714 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 178602 (New York) | Secondary |
207RC0200X | Internal Medicine - Critical Care Medicine | 178602 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hudson Valley Hospital Center | Cortlandt manor, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Westchester Medical Practice Pc | 9335238732 | 147 |
News Archive
Bionik Laboratories Corp., a pioneering medical device and robotics company with a focus in developing transformational technologies and solutions for individuals with neurological disorders, announced that shares of the Company's common stock will begin trading today on the OTCQX® Best Market under its existing ticker symbol "BNKL."
A novel drug designed to lessen muscle damage from a heart attack has passed initial safety tests at the Duke Clinical Research Institute.
Quanterix announce pricing of previously announced underwritten public offering of 2,376,238 shares of common stock public offering price of $25.25 per share.
ZIOPHARM Oncology, Inc. announced today that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in a public offering. JMP Securities LLC and Rodman & Renshaw, LLC are acting as co-lead managers for the offering.
› Verified 4 days ago
Entity Name | The Westchester Medical Practice Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225222953 PECOS PAC ID: 9335238732 Enrollment ID: O20080502000160 |
News Archive
Bionik Laboratories Corp., a pioneering medical device and robotics company with a focus in developing transformational technologies and solutions for individuals with neurological disorders, announced that shares of the Company's common stock will begin trading today on the OTCQX® Best Market under its existing ticker symbol "BNKL."
A novel drug designed to lessen muscle damage from a heart attack has passed initial safety tests at the Duke Clinical Research Institute.
Quanterix announce pricing of previously announced underwritten public offering of 2,376,238 shares of common stock public offering price of $25.25 per share.
ZIOPHARM Oncology, Inc. announced today that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in a public offering. JMP Securities LLC and Rodman & Renshaw, LLC are acting as co-lead managers for the offering.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jeffrey Beechert, MD 1980 Crompond Rd, Cortlandt Manor, NY 10567-4144 Ph: (914) 734-3600 | Dr Jeffrey Beechert, MD 1980 Crompond Rd, Cortlandt Manor, NY 10567-4144 Ph: (914) 734-3600 |
News Archive
Bionik Laboratories Corp., a pioneering medical device and robotics company with a focus in developing transformational technologies and solutions for individuals with neurological disorders, announced that shares of the Company's common stock will begin trading today on the OTCQX® Best Market under its existing ticker symbol "BNKL."
A novel drug designed to lessen muscle damage from a heart attack has passed initial safety tests at the Duke Clinical Research Institute.
Quanterix announce pricing of previously announced underwritten public offering of 2,376,238 shares of common stock public offering price of $25.25 per share.
ZIOPHARM Oncology, Inc. announced today that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in a public offering. JMP Securities LLC and Rodman & Renshaw, LLC are acting as co-lead managers for the offering.
› Verified 4 days ago
Robert Rosenbaum, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1980 Crompond Rd, Cortlandt Manor, NY 10567 Phone: 914-737-6117 Fax: 914-734-3926 | |
Dr. Laura Greene Wiegand, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1983 Crompond Rd, Cortlandt Manor, NY 10567 Phone: 914-736-1100 Fax: 714-736-2071 | |
Vadim Nobel, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1980 Crompond Rd, Cortlandt Manor, NY 10567 Phone: 914-734-3600 Fax: 914-734-3601 | |
James C. Trapasso, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1985 Crompond Rd, Suite 1, Cortlandt Manor, NY 10567 Phone: 914-739-6550 Fax: 914-739-4575 | |
Mr. Aaron David Richman, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1985 Crompond Rd, Bldg D, Cortlandt Manor, NY 10567 Phone: 914-739-6550 Fax: 914-739-4575 | |
Dr. Kola Dushaj, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2084 E Main St, Cortlandt Manor, NY 10567 Phone: 914-739-4800 Fax: 914-468-2570 | |
Dr. Ricardo Esquitin, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1978 Crompond Rd, Suite #202, Cortlandt Manor, NY 10567 Phone: 914-736-0703 |